Home/Filings/4/0001209191-17-004597
4//SEC Filing

ACHILLION PHARMACEUTICALS INC 4

Accession 0001209191-17-004597

CIK 0001070336operating

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 5:20 PM ET

Size

5.5 KB

Accession

0001209191-17-004597

Insider Transaction Report

Form 4
Period: 2017-01-17
Apelian David
EVP and Chief Medical Officer
Transactions
  • Award

    Employee Stock Option

    2017-01-17+185,000185,000 total
    Exercise: $4.11Exp: 2027-01-17Common Stock (185,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070336

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:20 PM ET
Size
5.5 KB